Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Tirzepatide remained the leading AOM and ADM by prescription volume and showed the largest increase in total prescribing from September to December 2025
A year after stopping, they were still down about 6% from their starting weight, compared with about 3% in those who didnt receive additional support
Retatrutide Retatrutide is a multi-receptor peptide agonist targeting GLP-1, GIP, and glucagon receptors, developed for the treatment of obesity and type 2 diabetes
Thats why we introduced these new options making Ro one of the most affordable places to get started on GLP-1 treatment and access high-quality care
US$ 27.70
US$ 21.45
US$ 22.85
US$ 27.20
US$ 23.39
